Bob Siegerink
Bob Siegerink
dept clinical epidemiology
Потвърден имейл адрес: lumc.nl - Начална страница
The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19
FA Klok, GJAM Boon, S Barco, M Endres, JJM Geelhoed, S Knauss, ...
European Respiratory Journal 56 (1), 2020
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study
RT Urbanus, B Siegerink, M Roest, FR Rosendaal, PG de Groot, A Algra
The Lancet Neurology 8 (11), 998-1005, 2009
Graphical presentation of confounding in directed acyclic graphs
MM Suttorp, B Siegerink, KJ Jager, C Zoccali, FW Dekker
Nephrology Dialysis Transplantation 30 (9), 1418-1423, 2015
Contribution of established stroke risk factors to the burden of stroke in young adults
A Aigner, U Grittner, A Rolfs, B Norrving, B Siegerink, MA Busch
Stroke 48 (7), 1744-1751, 2017
High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women
HM Andersson, B Siegerink, BM Luken, JTB Crawley, A Algra, DA Lane, ...
Blood, The Journal of the American Society of Hematology 119 (6), 1555-1560, 2012
Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis
AH Nave, KS Lange, CO Leonards, B Siegerink, W Doehner, ...
Atherosclerosis 242 (2), 496-503, 2015
Association between dispatch of mobile stroke units and functional outcomes among patients with acute ischemic stroke in Berlin
M Ebinger, B Siegerink, A Kunz, M Wendt, JE Weber, E Schwabauer, ...
Jama 325 (5), 454-466, 2021
Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?
CE Jacobi, GH de Bock, B Siegerink, CJ van Asperen
Breast cancer research and treatment 115, 381-390, 2009
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study
D Munblit, T Nicholson, A Akrami, C Apfelbacher, J Chen, W De Groote, ...
The Lancet Respiratory Medicine, 2022
Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19
FVC Machado, R Meys, JM Delbressine, AW Vaes, YMJ Goërtz, ...
Health and quality of life outcomes 19, 1-10, 2021
Intrinsic Coagulation Activation and the Risk of Arterial Thrombosis in Young Women; Results From the Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO …
B Siegerink, JWP Govers-Riemslag, FR Rosendaal, H Ten Cate, A Algra
Circulation 122 (18), 1854-1861, 2010
Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke
B Siegerink, FR Rosendaal, A Algra
Journal of thrombosis and haemostasis 7 (3), 385-390, 2009
Where have all the rodents gone? The effects of attrition in experimental research on cancer and stroke
C Holman, SK Piper, U Grittner, AA Diamantaras, J Kimmelman, ...
PLoS biology 14 (1), e1002331, 2016
Association of high body mass index with decreased treatment response to combination therapy in recent‐onset rheumatoid arthritis patients
L Heimans, M Van Den Broek, S le Cessie, B Siegerink, N Riyazi, KH Han, ...
Arthritis care & research 65 (8), 1235-1242, 2013
Mendelian randomization: use of genetics to enable causal inference in observational studies
M Verduijn, B Siegerink, KJ Jager, C Zoccali, FW Dekker
Nephrology dialysis transplantation 25 (5), 1394-1398, 2010
Thrombo-inflammation in cardiovascular disease: an expert consensus document from the third Maastricht consensus conference on thrombosis
E d’Alessandro, C Becker, W Bergmeier, C Bode, JH Bourne, H Brown, ...
Thrombosis and haemostasis 120 (04), 538-564, 2020
Role of obesity in the etiology of deep vein thrombosis and pulmonary embolism: current epidemiological insights
SK Braekkan, B Siegerink, WM Lijfering, JB Hansen, SC Cannegieter, ...
Seminars in thrombosis and hemostasis 39 (05), 533-540, 2013
Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up …
B Siegerink, R Maas, CY Vossen, E Schwedhelm, W Koenig, R Böger, ...
Clinical Research in Cardiology 102, 193-202, 2013
Plasma ADAMTS‐13 levels and the risk of myocardial infarction: an individual patient data meta‐analysis
A Maino, B Siegerink, LA Lotta, JTB Crawley, S le Cessie, FWG Leebeek, ...
Journal of Thrombosis and Haemostasis 13 (8), 1396-1404, 2015
Hypercoagulability is a stronger risk factor for ischaemic stroke than for myocardial infarction: a systematic review
A Maino, FR Rosendaal, A Algra, F Peyvandi, B Siegerink
PloS one 10 (8), e0133523, 2015
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20